f)?(f=C.consentTime,m&&ee("debug",'Consent time read from "'+l.controlCookie+'": ',f)):null!==f&&m&&ee("debug",'Consent time read from "'+l.confirmCookie+'": ',f);if(t=m&&H?" [GPC override]":"",null!==f?(d=!0,S=Ie(),d?(null!==C.consentTime&&C.consentTime=0&&(clearTimeout(e.WBD.UserConsent_wait),e.WBD.UserConsent_wait=-1),!e.OneTrust||"function"!=typeof e.OneTrust.GetDomainData){const n=L?e.OneTrustStub&&e.OneTrustStub.otSdkStub?t?3:4:2:1;return R=!1,Se(n),void(e.OptanonWrapper=function(){})}R=!0,l.geoPassedToOneTrust&&fe(),K?("function"!=typeof e.__gpp&&(e.__gpp=v),e.__gpp("ping",(function(t){if(!t||t.cmpId<=0)K=!1,N&&(N.setCmpStatus("error"),N.fireErrorEvent("CMP did not initialize GPP for this region.")),m&&ee("debug","OneTrust GPP for this region is broken. Disabling use of GPP.");else if(1===t.cmpId)J=!1,N?(m&&ee("debug","OneTrust did NOT initialize GPP for this region. Using GPP from UserConsent."),N.setCmpStatus("loaded"),N.fireEvent("cmpStatus","loaded"),N.setSignalStatus("ready"),N.fireEvent("signalStatus","ready")):(K=!1,m&&ee("debug","OneTrust did NOT initialize GPP for this region. UserConsent GPP failed to initialize. Disabling use of GPP."));else{const n=t.cmpStatus;A=t.cmpId,J=!0,t.gppVersion&&"1.0"===t.gppVersion&&(t=e.__gpp("getGPPData")),t&&t.gppString&&(P=t.gppVersion,t.gppString!==w&&(me(t.gppString,null),Pe())),m&&ee("debug",'OneTrust GPP initialized (status "'+n+'").')}n()}))):n()}},"object"==typeof e.WBD.UserConsentConfig&&null!==e.WBD.UserConsentConfig?xe(e.WBD.UserConsentConfig):"object"==typeof e.WM.UserConsentConfig&&null!==e.WM.UserConsentConfig&&xe(e.WM.UserConsentConfig)),{addScript:function(e,n,s,i){if(e&&(e.src||e.text)){const o={cact:"ADD",name:e.name||e.src||e.id||"unnamed inline"},r=s||t.head,a=i||["*"];if(!le(a))return m&&(u.push({ts:new Date,act:"ADD",desc:o.name,res:!1,note:"Not in script region"}),ee("debug","Check for region ["+(a.join(",")||"empty")+'] REJECTS "'+o.name+'", script NOT added')),!1;if(Ae(n,o)){const n=t.createElement("script"),s=Object.keys(e);for(let t=0;t {
if (
window.CNN.Zion.environmentType &&
window.CNN.Zion.sourceId &&
window.ZION_SDK
) {
const environment = window.ZION_SDK.EnvironmentType[window.CNN.Zion.environmentType];
const enableLogging = environment !== window.ZION_SDK.EnvironmentType.Prod;
if (window.zion_analytics) {
window.addEventListener('zionReady', (evt) => {
window.zion_analytics.track(new window.ZION_SDK.Pageview({
canonicalUrl: window.CNN.contentModel.canonicalUrl,
traits: {
event_source: window.CNN.contentModel.techStack || 'stellar',
page_variant: window.CNN.contentModel.templateType || '',
raw_url: window.location.href,
cms_id: CNN.contentModel.cmsId || '',
page_type: CNN.contentModel.pageType || '',
edition: window.CNN.helpers.isEditionPage(),
section: CNN.contentModel.section || '',
subsection: CNN.contentModel.subsection || '',
section_level_3: CNN.contentModel.subsubsection || '',
experience_type: 'cnn_core'
},
sourceId: window.CNN.contentModel.sourceId || ''
}), new ZION_SDK.ConsentContext({
consent_state: window.WBD.UserConsent.getSimpleConsentState() || {}
}));
}, {once: true});
window.zion_analytics.configure({
bridgeEnabled: true,
bufferSize: 20,
enableLogging,
customFeatureManagerPath: 'https://z.cdp-dev.cnn.com/zfm/zfh-3.js',
environment: window.CNN.Zion.environmentType,
isSecure: true,
telemetryEndpoint: window.env.ZION_TELEMETRY_ENDPOINT,
trackAdvertising: false,
trackBluetooth: false,
trackDeeplink: false,
trackLifecycle: false,
trackLocation: false,
trackNotifications: false,
trackPurchases: false,
trackScreens: false,
trackUxMetrics: true,
uxMetricsPercentage: 15
});
} else {
console.error('zion: "zion_analytics" failed to load properly.');
}
} else {
throw new Error('zion: missing either "apiKey", "environmentType" or "sourceId"');
}
});
})();
//script: sovrn
addScript({ async: false, defer: true, name: 'sovrn', src: 'https://get.s-onetag.com/c15ddde9-ec7d-4a49-b8ca-7a21bc4b943b/tag.min.js', loadEventName: 'sovrn', ucStates: ['iab','data-share','data-sell','data-store','ads-contextual','ads-person-prof','ads-person','content-person-prof','content-person','measure-ads','measure-content','measure-market','product-develop'] });
//script: fave
addScript({ async: false, defer: true, name: 'fave', src: 'https://registry.api.cnn.io/bundles/fave/latest-4.x/js', loadEventName: 'fave' });
//script: pym-js
addScript({ async: true, defer: false, name: 'pym-js', src: 'https://cdn.cnn.com/cnn/.e/interactive/js/lib/vendor/pym/pym.v1.min.js', loadEventName: 'pym-js' });
//script: distroscale
addScript({ async: false, defer: true, name: 'distroscale', src: 'https://a.jsrdn.com/creatives/23053/cw.js', loadEventName: 'distroscale', ucStates: ['iab','data-share','data-store','ads-contextual','content-person','measure-content','product-develop'] });
}())
Thank You!
Your effort and contribution in providing this feedback is much
appreciated.
Close
Ad Feedback
Ad Feedback
How safe is the abortion pill compared with other common drugs?
CNN
—
The Supreme Court unanimously rejected a lawsuit challenging the Food and Drug Administrationâs approach to regulating the abortion pill mifepristone with a ruling that will continue to allow the pills to be mailed to patients without an in-person doctorâs visit.
Data analyzed by CNN shows mifepristone â the first drug in the medication abortion process â is even safer than some common, low-risk prescription drugs, including penicillin and Viagra. There were five deaths associated with mifepristone use for every 1 million people in the US who have used the drug since its approval in 2000, according to the US Food and Drug Administration as of last summer. Thatâs a death rate of 0.0005%.
Comparatively, the risk of death by penicillin â a common antibiotic used to treat bacterial infections like pneumonia â is four times greater than it is for mifepristone, according to a study on life-threatening allergic reactions. Risk of death by taking Viagra â used to treat erectile dysfunction â is nearly 10 times greater, according to a study cited in the amicus brief filed by the FDA.
â[Mifepristone] has been used for over 20 years by over five million people with the capacity to become pregnant,â said Ushma Upadhyay, an associate professor in the department of obstetrics, gynecology and reproductive science at the University of California, San Francisco. âIts safety is very well established.â
Weighing medication abortion against the alternatives
The growing popularity of medication abortion is largely because of its accessibility, said Abigail Aiken, associate professor at the University of Texas at Austin who leads a research group on medication abortion.
âIt reduces the cost, it reduces barriers where people may not want to go to a clinic,â she said.
It is also a safer option than both procedural abortion or childbirth. The rate of major complications â like hemorrhages or infections â for medication abortions is about one-third of a percent, according to a 2015 study conducted by Upadhyay. That means out of more than 11,000 cases, 35 experienced any major complications.
The likelihood of serious complications via procedural abortion â performed second-trimester or later â is slightly higher than medication abortion at 0.41%, according to the same study. And childbirth by far comes with the highest risk, at 1.3%.
Although misoprostol-only abortions are used around the world, they are less effective, associated with a higher risk of serious complications and often more painful than the mifepristone and misoprostol combination, she said.
In a study of self-managed misoprostol-only medication abortions in the US, Johnson found misoprostol-only abortions to be a safe alternative, though less safe than using both pills. The study, published in February, analyzed data from online telehealth medication abortion provider Aid Access from 2020. Nearly 90% of 568 users reported completed abortions and 2% experienced serious complications using only misoprostol.
Mifepristone and misoprostol together is still considered the gold standard, Aiken told CNN. People who used the two-pill combination were less likely to experience serious complications than those who went with the misoprostol-only regimen.
âItâs clear people can use these medications, mifepristone and misoprostol, at home even without the help of a medical professional very safely,â said Aiken.
Because misoprostol is used to treat multiple ailments including stomach ulcers, itâs readily stocked in pharmacies and unlikely to be taken off the market anytime soon, Johnson told CNN in April.
However, a lesser-effective method means more people will likely have unsuccessful abortions.
âItâs possible that it might not work for some people, and it will prolong their abortions,â said Upadhyay. âThen by the time they get back to the clinic, theyâre seeking abortion later in pregnancy.â
CNNâs Devan Cole, Tierney Sneed and Amy OâKruk contributed to this report.
This updated story originally ran on March 15, 2023 and was updated on June 13, 2024.